Document is current
Any future updates will be listed below
-
Authors
Di Pasquale, Mattia
Ravassa, Susana
Pagnesi, Matteo
Pancaldi, Edoardo
López, Begoña
José, Gorka San
Gussago, Cristina
Fiorentino, Letizia
Ravera, Alice
Serafini, Lisa
Chizzola, Giuliano
Lombardi, Carlo Mario
Metra, Marco
González, Arantxa
Adamo, Marianna https://orcid.org/0000-0002-3855-1815
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (CIBERCV CB16/11/00483, PI24/00844 co-financed with ERDF funds)
Agencia Estatal de Investigación and Horizon Europe ERA4HEALTH CARDINNOV program (PCI2024-153490)
- License Information
-
More Information
Article History
Received: 22 April 2025
Accepted: 24 June 2025
First Online: 29 July 2025
Declarations
:
: Dr. Ravassa reports grants from Instituto de Salud Carlos III, grants from Agencia Estatal de Investigación & Horizon Europe. Dr. Pagnesi has received personal fees from Abbott Vascular, AstraZeneca, Boehringer Ingelheim, Novartis, Novo Nordisk, Roche Diagnostics, and Vifor Pharma. Dr. López reports grants from Instituto de Salud Carlos III, grants from Agencia Estatal de Investigación & Horizon Europe. Dr. San José reports grants from Instituto de Salud Carlos III and grants from Agencia Estatal de Investigación & Horizon Europe. Dr. Metra has received personal fees from Actelion, Amgen, Livanova, and Vifor Pharma as a member of executive or data monitoring committees of sponsored clinical trials and from AstraZeneca, Bayer, Boehringer Ingelheim, Edwards Lifesciences, and Novartis for participation in advisory boards or for speaking at sponsored meetings. Dr. González reports grants from Instituto de Salud Carlos III and grants from Agencia Estatal de Investigación & Horizon Europe. Marianna Adamo received consulting fees in the last 3 years from Abbott Structural Heart and Edwards LifeSciences.
